<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Guidelines from the ESC and ACC/<z:chebi fb="30" ids="27777">AHA</z:chebi> recommend implantable cardioverter defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e>) be implanted in clinically indicated patients with a reasonable expectation of &gt;1 year survival </plain></SENT>
<SENT sid="1" pm="."><plain>Our study aimed to assess if selected clinical markers of organ dysfunction were associated with increased 1-year mortality despite <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> therapy </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We retrospectively studied 283 patients with de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> implanted for primary or secondary prevention in <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischaemic heart disease</z:e> and <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the association of the following clinical markers of organ dysfunction with 1 year mortality: <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo> (<z:chebi fb="0" ids="29995">aspartate</z:chebi> transaminase/alanine transaminase ≥ 3× upper limit of <z:mpath ids='MPATH_458'>normal</z:mpath> or prothrombin time/international normalized ratio ≥ 1.5 in the absence of anticoagulation), respiratory dysfunction (recent mechanical ventilation within 3 months prior to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implant), <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> (<z:chebi fb="0" ids="16737">creatinine</z:chebi> ≥150 µmol/L or glomerular filtration rate ≤ 30 mL/min/1.73 m(2)), <z:hpo ids='HP_0001903'>anaemia</z:hpo> (Hb ≤ 100 g/L), and prior cerebral vascular injury </plain></SENT>
<SENT sid="4" pm="."><plain>With no organ dysfunction, 1 year mortality was 1.9% </plain></SENT>
<SENT sid="5" pm="."><plain>In the presence of a <z:e sem="disease" ids="C0349410" disease_type="Disease or Syndrome" abbrv="">single organ dysfunction</z:e>, mortality was increased to 14.3% </plain></SENT>
<SENT sid="6" pm="."><plain>With two or more markers of organ dysfunction mortality was 38.1% at 1 year (log-rank test P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Clinical markers of <z:hpo ids='HP_0001410'>liver dysfunction</z:hpo>, recent mechanical ventilation, and <z:e sem="disease" ids="C0341697" disease_type="Disease or Syndrome" abbrv="">renal impairment</z:e> were independently associated with increased 1 year mortality </plain></SENT>
<SENT sid="8" pm="."><plain>Presence of more than one clinical marker of organ dysfunction was associated with significantly increased risk of mortality in our study </plain></SENT>
</text></document>